Mitral Valve Disease Market, By Treatment Type, By Indication, By Device Type, By End User, By Geography

Description

Global mitral valve disease market is estimated to be valued at USD 2.80 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 2.80 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	9.00%	2031 Value Projection:	US$ 5.12 Bn

Figure. Mitral Valve Disease Market Share (%), By Region 2024

Mitral valve disease refers to conditions that affect the mitral valve located between the left atrium and left ventricle of the heart. Mitral valve plays a key role in regulating blood flow from the left atrium to the left ventricle. Some common types of mitral valve disease include mitral valve stenosis, which causes narrowing or blockage of the mitral valve, and mitral valve regurgitation or insufficiency, which allows blood to flow backward through the mitral valve. Factors such as aging, rheumatic fever, congenital heart defects, and infections can damage the mitral valve and lead to diseases. Presently, there is no cure for mitral valve disease, however, treatments aim to repair or replace the damaged mitral valve via procedures such as mitral valve repair or replacement surgeries.

Market Dynamics

Global mitral valve disease market growth is driven by rising geriatric population globally who are more prone to develop mitral valve diseases due to age-related degeneration of heart valves. Increasing prevalence of rheumatic heart disease in developing nations can drive the market growth during the forecast period. However, high costs associated with mitral valve repair and replacement surgeries along with lack of skilled healthcare professionals can hamper the market growth. Ongoing development of novel mitral valve repair technologies and techniques present lucrative growth opportunities for market players.

Key Features of the Study

This report provides in-depth analysis of the global mitral valve disease market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global mitral valve disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Corcym UK Limited, Artivion, Inc., ShockWave Medical, Inc., Valcare Medical, Braile Biomedica, Labcor Laboratorios Ltda, Zydus Lifesciences Limited, Affluent Medical, Teva Pharmaceutical Industries Ltd., Bayer AG, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global mitral valve disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mitral valve disease market

Market Segmentation

Treatment Type Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Repair
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
- Mitral Valve Replacement
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
- Cardiac Resynchronization Therapy (CRT)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
- Mitral Valve Therapeutics
- Pharmacological Treatments
- Device-Based Therapies
Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Mitral Valve Regurgitation
- Mitral Valve Stenosis
- Mitral Valve Prolapse
Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Surgical Instruments
- Heart-Lung Machines
- Surgical Staplers
- Sutures
- Implant Devices
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
- Diagnostic Devices
- Echocardiograms
- Cardiac Imaging Systems
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Cardiac Rehabilitation Centers
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
Key Players Insights
- Edwards Lifesciences Corporation
- Medtronic Plc
- Abbott Laboratories
- Boston Scientific Corporation
- Corcym UK Limited
- Artivion, Inc.
- ShockWave Medical, Inc.
- Valcare Medical
- Braile Biomedica
- Labcor Laboratorios Ltda
- Zydus Lifesciences Limited
- Affluent Medical
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Novartis AG

Product Code: CMI7572

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Mitral Valve Disease Market, By Treatment Type
- Global Mitral Valve Disease Market, By Indication
- Global Mitral Valve Disease Market, By Device Type
- Global Mitral Valve Disease Market, By End User
- Global Mitral Valve Disease Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Mitral Valve Disease Market, By Treatment Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Mitral Valve Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair
Mitral Valve Replacement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mechanical Valve Replacement
- Biological Valve Replacement
- Transcatheter Aortic Valve Replacement (TAVR)
Cardiac Resynchronization Therapy (CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biventricular Pacing
- Implantable Cardioverter Defibrillators (ICDs)
Mitral Valve Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pharmacological Treatments
- Device-Based Therapies

5. Global Mitral Valve Disease Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Mitral Valve Regurgitation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mitral Valve Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mitral Valve Prolapse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Mitral Valve Disease Market, By Device Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Surgical Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Heart-Lung Machines
- Surgical Staplers
- Sutures
Implant Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mitral Valve Prostheses
- Repair Devices (e.g., annuloplasty rings)
Diagnostic Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Echocardiograms
- Cardiac Imaging Systems

7. Global Mitral Valve Disease Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiac Rehabilitation Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Mitral Valve Disease Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
Corcym UK Limited
Artivion, Inc.
ShockWave Medical, Inc.
Valcare Medical
Braile Biomedica
Labcor Laboratorios Ltda
Zydus Lifesciences Limited
Affluent Medical
Teva Pharmaceutical Industries Ltd.
Bayer AG
Novartis AG

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us